Immune globulin - GC Pharma

Drug Profile

Immune globulin - GC Pharma

Alternative Names: GC-5101B; GC5107; GC5107A; I.V.-Globulin SN inj.; IGIV-SN; IVIG 10%

Latest Information Update: 07 Feb 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Green Cross
  • Developer GC Pharma
  • Class Antidementias; Antivirals; Immunoglobulins; Immunoproteins; Serum globulins
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Agammaglobulinaemia; Guillain-Barre syndrome; Infections; Mucocutaneous lymph node syndrome
  • Preregistration Immunodeficiency disorders
  • Phase III Thrombocytopenia

Most Recent Events

  • 10 Apr 2018 Green Cross Corporation plans a phase III trial for Immunodeficiency-disorders in June 2018 , (NCT03492710)
  • 03 Dec 2016 Efficacy, pharmacokinetc and adverse event data from a phase III trial in Thrombocytopenia presented at the 58th Annual Meeting and Exposition of the American Society of Hematology (ASH-2016)
  • 01 Jun 2016 Green Cross initiates enrolment in a phase III trial for Immunodeficiency disorders in Canada (NCT02783482)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top